Quest Diagnostics Inc. (DGX) will raise its quarterly dividend by 5.7 percent to $0.56 per share in the first quarter of 2020. This marks the 10th consecutive year of annualized dividend increases by the clinical lab results database provider.

The increased dividend is payable on April 21, 2020 to shareholders of record of Quest Diagnostics common stock on April 7, 2020. A new annualized dividend rate of $2.24 per share yields 2.0% at a stock price of $110.67. This dividend increase is the company's ninth since 2011.

Quest Diagnostics Incorporated is a provider of diagnostic information services. Quest Diagnostics ows the world's largest database of clinical lab results and the company's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. DGX's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.